Vulnerable and at-risk groups, including some people with multiple sclerosis (MS) will soon be able to spend time outside their homes, the Health and Social Care Secretary has announced.
From Monday...
A new study has found the risk of a relapse for someone with relapsing remitting multiple sclerosis (RRMS) switching from Tysabri (natalizumab) to another injectable or oral after two or more years...
Have you ever dreamed of completing a marathon? Well, this July you could do just that, as here at MS-UK, we’ve launched the UK’s most accessible marathon, in which anyone can take part regardless of...
New research has found that having multiple sclerosis (MS) is associated with an increased risk of acute coronary syndrome (ACS), stroke, and death, and the findings cannot be explained by...
Long-term treatment with fingolimod results in lesser disability in people with relapsing remitting multiple sclerosis (MS), a new study has found.
People treated with the drug for eight or more...
A new study from Italy has found that Sativex, a type of medical cannabis licensed in the UK for some symptoms of multiple sclerosis MS, eases symptoms related to spasticity, even in those with no...
An early study from Italy suggests people with multiple sclerosis (MS) may not have a higher risk of getting a severe COVID-19 infection.
Although the researchers said caution must be taken because...
Being obese is linked to a faster degeneration of optic nerve tissue in people with multiple sclerosis (MS) than in those of a normal body weight, a new study has found.
Researchers at Johns Hopkins...
Scientists have developed a new technique to diagnose early-stage multiple sclerosis (MS) and distinguish it from a similar autoimmune condition called neuromyelitis optica.
Brazilian researchers...
MS-UK are excited to announce we have been named the sixth best charity to work for in Britain.
We scooped the accolade in Third Sector’s Best Charities to Work For, which recognises employers in the...
